Researchers recently discovered that an experimental cancer vaccine offers "a promising approach" to preventing cancers from ...

Zev A. Wainberg, MD, discussed the significance of the AMPLIFY-201 trial, next steps for this vaccine platform, and the signs ...

Researchers found that the vaccine, named ELI-002 2P, could trigger lasting immune responses and may help prevent or delay ...

In a phase 1 study, ELI-002 2P improved relapse-free survival in pancreatic and colorectal cancer, with stronger benefit in ...

The vaccine would train the immune system to fight cancer-causing mutations, according to new research from UCLA Health.

For three colorectal cancer patients and three pancreatic cancer patients, the vaccine appeared to remove all disease ...

Phase 1 trial of a pancreatic cancer vaccine targeting mutant KRAS shows strong immune responses, extended survival, and ...

DENVER — Early data for a new vaccine for pancreatic cancer is generating some hope among patients, researchers and doctors.

A new study reveals promising results for a vaccine targeting colorectal and pancreatic cancers. Researchers from the ...

An 'off-the-shelf' vaccine may help prevent or delay cancer recurrence in people with hard-to-treat colorectal or pancreatic ...